NCT00202241
- Conditions
- AIDS, Acquired Immunodeficiency Syndrome, Blood-Borne Infections, +25 more
- Locations
-
- Queen's University Kingston, Ontario, Canada
Clinical trial condition
Sexually Transmitted Diseases
Explore clinical trials studying Sexually Transmitted Diseases. Study availability and eligibility vary by location and protocol.
6,127 public trials
376 recruiting studies
Sexually Transmitted Diseases trial results
Completed
Gut Associated Lymphatic Tissue (GALT) in HIV (Human Immunodeficiency Virus)- Infected Patients
NCT01679067
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
- Locations
-
- University of Cologne Cologne, Germany
NCT00202228
- Conditions
- AIDS, Acid-Base Imbalance, Acidosis, +25 more
- Locations
-
- Queen's University Kingston, Ontario, Canada
NCT00905489
- Conditions
- Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
- Locations
-
- 1100.1518.0001 Boehringer Ingelheim Investigational Site Washington D.C., District of Columbia, United States
- 1100.1518.0002 Boehringer Ingelheim Investigational Site Philadelphia, Pennsylvania, United States
- 1100.1518.2605 Boehringer Ingelheim Investigational Site Francistown, Botswana
- 1100.1518.2601 Boehringer Ingelheim Investigational Site Gaborone, Botswana
NCT01328041
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Beverly Hills, California, United States
- GSK Investigational Site Fountain Valley, California, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Los Angeles, California, United States
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
- Locations
-
- Spectrum Medical Group Phoenix, Arizona, United States
- AHF Research Center Beverly Hills, California, United States
- Pacific Oak Medical Group Beverly Hills, California, United States
- Kaiser Permanente Hayward, California, United States
Completed
Effect of Rifampin (RIF) on the Pharmacokinetics (PK) of Oral Cabotegravir (CAB) in Healthy Subjects
NCT02411435
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- GSK Investigational Site Overland Park, Kansas, United States
NCT02646605
- Conditions
- AIDS, Acquired Immunodeficiency Syndrome, Behavior, +18 more
- Locations
-
- Lighthouse Clinic Lilongwe, Malawi
NCT00908011
- Conditions
- Blood-Borne Infections, Communicable Diseases, Dyslipidemias, +17 more
- Locations
-
- St. Paul's Hospital HIV Immunodeficiency/Metabolic Clinic Vancouver, British Columbia, Canada
NCT00757783
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
- Locations
-
- Los Angeles, California, United States
- Glastonbury, Connecticut, United States
- Washington D.C., District of Columbia, United States
- Fort Lauderdale, Florida, United States